Early cancer detection for all.

Our mission

Ezra’s mission is to enable early cancer detection for everyone by using Artificial Intelligence and the most advanced medical imaging technology available.

Of the 18.1 million1 people who will be diagnosed with cancer this year, half will be diagnosed late2. And here’s the really alarming news: patients who detect cancer late are much less likely to survive than those who find it early. We need to rethink the way we approach cancer screening.

Our lives depend on it.

Our lives depend on it.

”At Ezra, we believe you should check your body for cancer as part of your routine health regimen. To make that possible, we’re combining a better patient experience with the most advanced medical imaging technology and the Ezra AI, with the goal of improving the speed, accuracy and affordability of cancer screening.

Our goal? Provide consumers with fast, accurate, pain-free MRI-based cancer screening. Offer access to expert radiologists, assisted by the Ezra AI. And compassionate, ongoing support from our team of Ezra Guides. Achieving this goal will remove the stress, anxiety, and human error from the cancer screening process. And give people a better way to take proactive care of their health year after year.”

Emi Gal, CEO & co-founder

We’re creating a new way to screen for prostate cancer, with other screening programs on the way.

Ultimately, our goal is to offer a whole-body MRI scan in a single session, and analyze it using the Ezra AI to quickly and accurately diagnose potential abnormalities anywhere in your body.

The Ezra AI is a technology currently in development that’s designed to make radiologists more accurate and more productive. The Ezra AI is an investigational device that has not received marketing authorization from the FDA, thus the safety and effectiveness of the device have not yet been established. After further study of our AI technology, we plan to seek FDA clearance and make the Ezra AI available to radiologists.

Our team

Our interdisciplinary team is composed of experts in computer science, deep learning, medical imaging and design.

Footnotes

The Ezra AI is an investigational device that has not received marketing authorization from the FDA, thus the safety and effectiveness of the device have not yet been established. After further study of our AI technology, we plan to seek FDA clearance and make the Ezra AI available to radiologists.